Haemophilus B is a type of influenza (flu) caused by bacteria. Haemophilus B bacteria can cause breathing problems or meningitis, and these infections can be fatal. Haemophilus B conjugate (PRP-T) vaccine is used to prevent this disease in children, and is sometimes combined with vaccines to protect against other diseases. This vaccine is given to children between the ages of 2 months and 18 months old. The vaccine works by exposing your child to a small amount of the bacteria or a protein from the bacteria, which causes the body to develop immunity to the disease. This vaccine will not treat an active infection that has already developed in the body, and will not protect against other types of influenza. Haemophilus B conjugate vaccine is not for use in children younger than 6 weeks. When used in combination with certain diphtheria vaccines, this vaccine may not be used in children younger than 15 months. Like any vaccine, haemophilus B conjugate vaccine may not provide protection from disease in every person.
Acthib is a vaccine. It prevents the infections brought about by Haemophilus influenza type b bacteria in pediatrics aged two months to five years. Acthib belongs to the class of drugs the Bacterial vaccines, and it is available in generic form as Haemophilus b conjugate vaccine (tetanus toxoid conjugate)/PF. Acthib acts by influencing one's immune system to make the antibodies that prevent H. influenza infections.